Hypertrophic and Keloid Scar Treatment Market Report 2025 (Global Edition)

Global Hypertrophic and Keloid Scar Treatment Market Report 2024 Market Size Split by Scar Type (Hypertrophic Scars, Keloid Scars), by Product (Topical Products, Creams, Gels, Silicone Sheets, Others,...

Hypertrophic and Keloid Scar Treatment Market Report Description

We have various report editions of Hypertrophic and Keloid Scar Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Hypertrophic and Keloid Scar Treatment Market Insights Video

Competitive Landscape of the Hypertrophic and Keloid Scar Treatment Market

There are a number of major companies active worldwide in the fiercely competitive hypertrophic and keloid scar treatment business. To increase their market presence, businesses are concentrating on strategic alliances, product development, and mergers and acquisitions. Major industry participants are devoting resources to research and development endeavors in order to present novel approaches to scar therapy and attain a competitive advantage. Both well-known pharmaceutical corporations and up-and-coming businesses providing cutting-edge scar treatment options are present in the market.

July 2022: Viora Ltd. was purchased by UK-based aesthetics company Sinclair Pharma for an unknown sum. Viora's minimally invasive and non-invasive cosmetic products will be acquired by Sinclair, facilitating the company's commercial entry into the US market. Medical aesthetic devices and treatments, including acne clearing and scar and stretch mark correction, are offered by Viora Ltd., a US-based company. (Source: https://americanmedspa.org/news/sinclair-announces-acquisition-of-viora) June 2022: The Phase 2a clinical study of OLX101A, an experimental therapy program for the treatment of hypertrophic scar, has concluded with patient enrollment, according to Olix Pharmaceuticals, Inc. The Company started recruiting patients for the Phase 2a clinical trial at five US sites in October 2020 after receiving FDA approval to further investigate OLX10010 (compound name of OLX101A). The purpose of the study is to determine if OLX10010 can effectively lower the incidence of hypertrophic scar recurrence following scar revision surgery. (Source: https://www.biospace.com/article/releases/olix-pharmaceuticals-announces-completion-of-enrollment-in-phase-2-clinical-trial-of-olx101a-in-patients-with-hypertrophic-scars/) February 2022: The Pharmaceuticals and Medical Devices Agency (PMDA) of Japan has given AVITA Medical, Inc. permission to sell the RECELL System there. In order to cure serious burns and drastically minimize the quantity of donor skin needed, the RECELL System is utilized to manufacture Spray-On Skin Cells from a small portion of the patient's skin. Depending on how severe the burn injury is, the device can be used at the point of care either by itself or in conjunction with autografts. (Source: https://ir.avitamedical.com/static-files/e0a67483-652d-4284-88f4-caf4d7cf36d0)

Top Companies Market Share in Hypertrophic and Keloid Scar Treatment Industry: (In no particular order of Rank)

• Smith & Nephew
• Merz Pharmaceuticals
• LLC
• Enaltus LLC
• Alliance Pharma
• PLC
• Sonoma Pharmaceuticals
• Inc.
• Molnlycke Health Care AB
• Lumenis
• Pacific World Corporation
• Perrigo Company PLC
• Cynosure
• Inc.
• Suneva Medical
• Inc.
• Newmedical Technology
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Hypertrophic and Keloid Scar Treatment Market

Which Region Dominates the Hypertrophic and Keloid Scar Treatment Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue The rising number of burn cases, trauma cases, and skin-related illnesses can all be attributable to this. Additionally, it is projected that the future expansion of this regional market will be further supported by the accessibility and quick uptake of cutting-edge methods for treating hypertrophic and keloid scars, namely laser therapies. In addition to the rise in skin-related illnesses, the growth is caused by the advancement of products for treating hypertrophic and keloid scars. In January 2020, for instance, Soliton, Inc. reported successful outcomes with its Rapid Acoustic Pulse Device. Fibrotic keloid and hypertrophic scars are the conditions for which the gadget is designed.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Hypertrophic and Keloid Scar Treatment market. This can be ascribed to the low cost of laser instruments and the ease of access to scar therapy goods with cutting edge technology in countries like China, Japan, India, etc. Furthermore, there is a growing market for over-the-counter topical medications. The goods are becoming more and more in demand because they can be purchased without a prescription. Treatments for keloid and hypertrophic scars are provided by numerous clinics and hospitals, which contributes to the expansion of the industry in the area.

 

The current report Scope analyzes Hypertrophic and Keloid Scar Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Hypertrophic and Keloid Scar Treatment Market

According to Cognitive Market Research, the global Hypertrophic and Keloid Scar Treatment market size was estimated at USD 6915.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2766.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Hypertrophic and Keloid Scar Treatment market with a market size of USD 2182.44 million in 2024 and is projected to grow at a CAGR of 9.6% during the forecast period because there have been more traffic accidents and burn cases, technical breakthroughs, and increased public awareness of the availability of cosmetic surgery.
• The Canada Hypertrophic and Keloid Scar Treatment market had a market share of USD 331.93 million in 2024 and is projected to grow at a CAGR of 10.6% during the forecast period driven by the increase in burn cases and car crashes in this country.
• The Mexico Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 251.71 million in 2024.

Europe Hypertrophic and Keloid Scar Treatment Market

According to Cognitive Market Research, the global Hypertrophic and Keloid Scar Treatment market size was estimated at USD 6915.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 2074.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031.

• The United Kingdom Hypertrophic and Keloid Scar Treatment market had a market share of USD 348.53 million in 2024 and is projected to grow at a CAGR of 10.9% during the forecast period because the number of facilities offering plastic surgery is rising.
• The France Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 190.86 million in 2024.
• According to Cognitive Market Research, the Germany Hypertrophic and Keloid Scar Treatment market size was valued at USD 410.76 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period because people's awareness of aesthetic attractiveness is growing.
• The Italy Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 178.41 million in 2024.
• The Russia Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 321.56 million in 2024.
• The Spain Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 9.2% during the forecast period with a market size of USD 170.11 million in 2024
• The Luxembourg Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 64.31 million in 2024.
• The Portugal Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 43.57 million in 2024.
• The Greece Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 24.89 million in 2024.
• Rest of Europe's Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 321.56 million in 2024.

Asia Pacific Hypertrophic and Keloid Scar Treatment Market

According to Cognitive Market Research, the global Hypertrophic and Keloid Scar Treatment market size was estimated at USD 6915.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1590.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

• According to Cognitive Market Research, the China Hypertrophic and Keloid Scar Treatment market size was valued at USD 715.72 million in 2024 and is projected to grow at a CAGR of 13.1% during the forecast period motivated by the rise in burn cases and auto accidents in this nation.
• The Japan Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 12.1% during the forecast period, with a market size of USD 219.49 million in 2024.
• The India Hypertrophic and Keloid Scar Treatment market had a market share of USD 190.86 million in 2024 and is projected to grow at a CAGR of 15.4% during the forecast period due to an increase in burn cases and traffic accidents, technological advancements, and public awareness of the availability of cosmetic surgery.
• The South Korea Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 159.05 million in 2024.
• The Australia Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 82.71 million in 2024.
• The South East Asia Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 14.6% during the forecast period, with a market size of USD 109.74 million in 2024.
• The Rest of Asia Pacific Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 112.93 million in 2024.

South America Hypertrophic and Keloid Scar Treatment Market

According to Cognitive Market Research, the global Hypertrophic and Keloid Scar Treatment market size was estimated at USD 6915.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 345.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Hypertrophic and Keloid Scar Treatment market size was valued at USD 147.99 million in 2024 and is projected to grow at a CAGR of 11.6% during the forecast period because there are more and more clinics providing plastic surgery.
• Argentina Hypertrophic and Keloid Scar Treatment market had a market share of USD 58.09 million in 2024 and is projected to grow at a CAGR of 11.9% during the forecast period as a greater awareness of visual appeal is spreading among individuals.
• Colombia Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.8% during the forecast period with a market size of USD 30.77 million in 2024.
• Peru Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 11.2% during the forecast period with a market size of USD 28.35 million in 2024.
• Chile Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 11.3% during the forecast period with a market size of USD 24.89 million in 2024.
• The Rest of Latin America Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 55.67 million in 2024.

Middle East and Africa Hypertrophic and Keloid Scar Treatment Market

According to Cognitive Market Research, the global Hypertrophic and Keloid Scar Treatment market size was estimated at USD 6915.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 138.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.

• The GCC Countries Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 12.1% during the forecast period with a market size of USD 59.19 million in 2024 because of a rise in traffic accidents, burn cases, and public knowledge of the availability of cosmetic surgery.
• The Egypt Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 11.6% during the forecast period, with a market size of USD 14.52 million in 2024.
• The South Africa Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 21.85 million in 2024 influenced by the surge in vehicle accidents and burn cases in the country.
• The Turkey Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 11.89 million in 2024.
• The Nigeria Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 14.52 million in 2024.
• The Rest of MEA Hypertrophic and Keloid Scar Treatment market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 16.32 million in 2024.

Hypertrophic and Keloid Scar Treatment Market Analysis

Hypertrophic and Keloid Scar Treatment Market Scar Type Segment Analysis

According to Cognitive Market Research, Keloid Scars stands out as the dominating category. Keloid scars can grow wide and extend beyond the region of the wound. These scars also have a high likelihood of recurrence and are more difficult to heal. Keloid scars also carry a significant chance of developing into cancerous cells. Furthermore, these scars never go away on their own and do not heal naturally. Thus, throughout the projected period, the keloid scar type is anticipated to dominate and increase at the highest rate due to the variables above.

Hypertrophic Scars emerge as the fastest-growing category in the Hypertrophic and Keloid Scar Treatment market due to the features of scars that are hypertrophic. Hypertrophic scars remain in the location of the wound. In addition, these are easier to treat and less common than keloid scars. In addition, unlike keloid scars, hypertrophic scars may eventually fade from view, which is why many people decide not to treat them. Therefore, it is expected that hypertrophic scars will grow at a relatively modest rate because of the aforementioned characteristics.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Hypertrophic and Keloid Scar Treatment Industry. Request a Free Sample PDF!

Hypertrophic and Keloid Scar Treatment Market Product Segment Analysis

According to Cognitive Market Research, the dominating category is topical. This dominance can be linked to the increased application of topical treatments for hypertrophic and keloid scars, such as gels, silicone sheets, and lotions. These topical medications are often purchased because they are easily accessible to consumers as over-the-counter (OTC) medications. Furthermore, these goods eliminate the requirement for a patient to see a doctor in order to receive medication, making them a simple and reasonably priced substitute. Therefore, it is projected that the topical products segment will lead the industry during the time under consideration as a result of the previously mentioned considerations.

The fastest-growing category in the Hypertrophic and Keloid Scar Treatment market is laser products. This is explained by the benefits that laser treatment offers to the patient. Laser treatment, for example, eliminates deep pitting and scarring. Additionally, all skin types and scar types can safely undergo laser treatment, which is less abrasive than older procedures. Furthermore, a Medscape study found that hypertrophic scars treated with 1.8 laser treatments showed an average improvement of 77%. Because of the aforementioned factors, the laser product treatment is predicted to expand at the fastest rate during the course of the projected period.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Hypertrophic and Keloid Scar Treatment End Use Segment Analysis

End Use Segment Analysis

According to Cognitive Market Research, the dominating category is hospitals. This can be attributed to both an increase in hospital admissions and an increase in the total number of hospitals worldwide. For instance, research by the American Hospital Association 2022 edition estimated that there were roughly 6,093 hospitals in the United States in 2020. Thus, it is expected that the market for hypertrophic and keloid scar therapy will grow during the forecast period due to the rise in hospitals and hospital admissions brought on by traffic accidents.

The fastest-growing category in the Hypertrophic and Keloid Scar Treatment market is Retail pharmacies/ e-commerce. This is explained by the way that products are made available. For instance, over-the-counter products include things like silicone sheets, lotions, and gels. These goods are & widely accessible without a doctor's prescription. Additionally, businesses everywhere are collaborating with different e-commerce platforms like Amazon.

• Hospitals
• Clinics
• Retail pharmacies/ e-commerce

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion